Search Results for:

ACRO AI/ML Committee Releases Principles for Responsible AI

WASHINGTON–Representing clinical research organizations (CROs) and clinical technology companies actively engaged in developing and deploying AI tools to support and improve drug development functions, ACRO is pleased to announce the release of ACRO’s Principles for Responsible AI. Drafted by a team of CRO and technology subject matter experts, the ACRO Principles articulate an approach to the

ACRO AI/ML Committee Releases Principles for Responsible AI Read More »

How much do you know about Risk-Based Monitoring (RBM)

Risk based monitoring is an adaptive approach that directs monitoring focus and activities to the evolving areas of greatest need which have the most potential to impact patient safety and data quality. How much do you know about Risk-Based Monitoring (RBM)? This webinar series from ACRO’s CRO Forum and The Society for Clinical Research Sites (SCRS) aims to educate

How much do you know about Risk-Based Monitoring (RBM) Read More »

Sandy Kennedy

Cassandra Strickland Kennedy has served as Chief Quality, Regulatory Affairs, and Sustainability Officer since May 2023 with oversight of Global Regulatory Compliance, Quality Assurance and Environmental, Social and Governance at Fortrea. Sandy brings more than three decades of biopharmaceutical industry experience, with a long track record of success in leadership positions within the pharmaceutical and

Sandy Kennedy Read More »

Risk-based Monitoring in Clinical Trials: Past, Present & Future

ACRO’s RBQM report shows how clinical trials were forced to shift to remote monitoring during the COVID-19 pandemic, and highlights why the industry shouldn’t turn back. Risk-based monitoring (RBM) is a powerful tool for efficiently ensuring patient safety and data integrity in a clinical trial, enhancing overall trial quality. To better understand the RBM implementation

Risk-based Monitoring in Clinical Trials: Past, Present & Future Read More »

Scroll to Top